Ostn - osteocrin

Predicted to enable signaling receptor binding activity. Predicted to be involved in hormone-mediated signaling pathway and negative regulation of dendrite extension. Predicted to act upstream of or within several processes, including endochondral bone growth; negative regulation of glucose import; and negative regulation of osteoblast differentiation. Predicted to be active in extracellular space. Orthologous to human OSTN (osteocrin). [provided by Alliance of Genome Resources, Apr 2022]